SCHEMBL3763585

SCHEMBL3763585

CN1CCC(N(C)C(=O)c2cccc(-c3cc(-c4c(N5CCOCC5)sc5c4CC(C)(C)CC5=O)ccn3)c2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
TGFBR1 P36897 1/20 0.37
LRRK2 Q5S007 1/20 0.36
PIK3CA P42336 3/20 0.33
MTOR P42345 2/20 0.33
DYRK1A Q13627 1/20 0.33
ATR Q13535 1/20 0.33
ATRIP Q8WXE1 1/20 0.33
BUB1 O43683 1/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPK14 Q16539 1/20 0.33
JMJD6 Q6NYC1 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CB P42338 1/20 0.32
PIK3CG P48736 1/20 0.32
FYN P06241 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3756109 0.96 BTK (0.36) ADORA2AADORA1TGFBR1LRRK2ATR
Formic Acid SCHEMBL16161933 0.93 BTK (0.34) ADORA2AADORA1TGFBR1LRRK2JMJD6
SCHEMBL3762316 0.90 LRRK2 (0.41) ADORA2ALRRK2PIK3CAMTORATR
SCHEMBL3767207 0.88 BRAF (0.39) TGFBR1PIK3CAMTORATRBUB1
SCHEMBL3761442 0.87 MTOR (0.38) LRRK2PIK3CAMTORATRATRIP
SCHEMBL3759043 0.87 MTOR (0.38) LRRK2PIK3CAMTORATRATRIP
SCHEMBL16161748 0.87 PIK3CD (0.37) ATRBUB1JMJD6PIK3CD
SCHEMBL3767645 0.86 ALDH1A1 (0.38) LRRK2PIK3CAMTORBUB1ALDH1A1
SCHEMBL3767531 0.86 PIK3CA (0.46) PIK3CAMTORMEN1KMT2APIK3CD
SCHEMBL3762759 0.86 PRKDC (0.40) PIK3CABUB1ALDH1A1JMJD6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA ADORA2A 3962/4885ADORA1 4599/4885TGFBR1 1914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.